Drawbacks to fully ablative laser resurfacing include significant downtime and extensive wound care, "so it’s not for everybody," says Arisa E. Ortiz, MD.
Recalled in 2022, a port delivery system for ranibizumab to treat wet AMD demonstrated that vision and retinal anatomy remained stable in patients who had the device for 5 years.